Steve Schonfeld’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-50,000
Closed -$1.65M – 2138
2021
Q3
$1.65M Buy
+50,000
New +$1.95M 0.02% 780

Other funds holding AXSM

Steve Schonfeld's AXSM Position: Q3 2026 in Review

Steve Schonfeld reduced its Axsome Therapeutics (AXSM) stake by 59% in Q3 2026, selling an estimated $4.61M and leaving 14,435 shares worth $2.66M. The position accounts for 0.01% of the portfolio, ranked #987.

Steve Schonfeld first reported a position in AXSM in Q1 2019 and has held it in 23 quarters since. The position peaked at $15.7M in Q2 2019. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Steve Schonfeld held 14,435 shares of Axsome Therapeutics worth $2.66M as of Q3 2026.
  • Steve Schonfeld sold 21,173 Axsome Therapeutics shares in Q3 2026, an estimated $4.61M.
  • Axsome Therapeutics made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #987 holding.
  • Steve Schonfeld first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 23 quarters since.
  • Steve Schonfeld's Axsome Therapeutics position peaked at $15.7M in Q2 2019.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.